BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4582263)

  • 1. The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments.
    Mendell JR; Whitaker JN; Engel WK
    J Immunol; 1973 Sep; 111(3):847-56. PubMed ID: 4582263
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia gravis: cross-striational fluorescence of muscle fibers mediated by Fc fragments.
    Aarli JA; Closs O
    J Immunol; 1972 Aug; 109(2):271-4. PubMed ID: 4558536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibodies to striated muscle in myasthenia gravis, demonstration of specific reactivity of F (ab')2-piece (author's transl)].
    Knapp W; Pateisky K
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jun; 143(5):477-82. PubMed ID: 4282930
    [No Abstract]   [Full Text] [Related]  

  • 4. Fc binding of IgG to skeletal muscle tissue.
    Aarli JA; Tönder O
    Int Arch Allergy Appl Immunol; 1974; 47(2):273-84. PubMed ID: 4368723
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-receptor striated muscle antibodies in sera from patients with myasthenia gravis.
    Aarli JA; Flood PR; Gilhus NE; Hofstad H; Matre R
    Monogr Allergy; 1988; 25():128-34. PubMed ID: 2971876
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis.
    Aarli JA; Mattsson C; Heilbronn E
    Scand J Immunol; 1975; 4(8):849-52. PubMed ID: 1215840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against myoid thymic cells and striated muscle, and monoclonal gammapathy in myasthenia gravis.
    Faure A; Gattegno L; Modigliani E; Sebaoun J; Eyquem A; Cornillot P
    Biomedicine; 1975 Jun; 23(6):241-5. PubMed ID: 813790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle antibodies in myasthenia gravis.
    Vetters JM
    Immunology; 1967 Sep; 13(3):275-80. PubMed ID: 4861494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis. Immunologic aspects].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):819-21. PubMed ID: 4103765
    [No Abstract]   [Full Text] [Related]  

  • 11. On the significance of the anti-muscle and erythrocyte membrane factors in systemic lupus erythematosus.
    Arimori S; Nakata Y
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):970-5. PubMed ID: 4633772
    [No Abstract]   [Full Text] [Related]  

  • 12. Skeletal and heart muscle antibodies in myasthenia gravis. A new immunofluorescence pattern.
    Cossio PM; Cornejo L; Herrera M; Vasquez C; Arana RM
    Biomedicine; 1973 Jun; 19(6):261-6. PubMed ID: 4584701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myasthenia with monoclonal kappa IgM gammapathy and presence of anti-striated muscle antibodies].
    Modigliani E; Charbord P; Landman C; Delzant G; Faure A; Gattegno L; Cornillot P; Sebaoun J
    Ann Med Interne (Paris); 1973 Mar; 124(3):193-200. PubMed ID: 4577478
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE; Aarli JA; Matre R
    Acta Neurol Scand; 1983 Nov; 68(5):328-36. PubMed ID: 6364682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A search for antibodies to neuronal nuclei in the serum of patients with myasthenia gravis.
    Whitaker JN; Engel WK
    Neurology; 1974 Jan; 24(1):61-3. PubMed ID: 4589357
    [No Abstract]   [Full Text] [Related]  

  • 16. Evans blue as counterstain in the demonstration of muscle antibodies by immunofluorescence in myasthenia gravis.
    Closs O; Aarli JA
    J Clin Pathol; 1974 Feb; 27(2):162-7. PubMed ID: 4132968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimuscle factor and antinuclear factor in patients with myasthenia gravis. 1. Heavy chain determinants.
    McFarlin DE; Johnson JS SEYMOUR WF
    J Immunol; 1968 Jul; 101(1):104-10. PubMed ID: 4173933
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence of positive anti-muscle membrane and anti-erythrocyte membrane antibodies in the sera of patients].
    Arimori S; Nakata Y; Takeo O
    Igaku To Seibutsugaku; 1971 Aug; 83(2):67-70. PubMed ID: 5169481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological study on myasthenia gravis].
    Arimori S
    Saishin Igaku; 1969 Jun; 24(6):1268-76. PubMed ID: 4896524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.